Search Results - "Berger, M.S."

Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging by Cha, S, Lupo, J.M, Chen, M.-H, Lamborn, K.R, McDermott, M.W, Berger, M.S, Nelson, S.J, Dillon, W.P

“…Glioblastoma multiforme (GBM) and single brain metastasis (MET) are the 2 most common malignant brain tumors that can appear similar on anatomic imaging but…”
Get full text

Sub-centimeter language organization in the human temporal lobe by Flinker, A., Chang, E.F., Barbaro, N.M., Berger, M.S., Knight, R.T.

“…The human temporal lobe is well known to be critical for language comprehension. Previous physiological research has focused mainly on non-invasive…”
Get full text

A Phase 2 Study of Temozolomide in the Treatment of Adult Patients With Supratentorial Low-Grade Glioma by Wahl, M, Aicardi, J, Haas-Kogan, D.A, Butowski, N, Clarke, J, Prados, M, Phillips, J, Berger, M.S, Chang, S

Get full text

Omission of Radiation Therapy for Low-Grade Gliomas: Molecular and Radiographic Correlates of Treatment Response and Disease Progression on a Phase 2 Clinical Trial of Adjuvant Temozolomide by Wahl, M, Phillips, J, Molinaro, A, Lin, Y, Perry, A, Haas-Kogan, D.A, Costello, J, Dayal, M, Butowski, N, Clarke, J, Prados, M, Berger, M.S, Nelson, S, Chang, S.M

Get full text

Pro-angiogenic cellular and genomic expression patterns within glioblastoma influences dynamic susceptibility weighted perfusion MRI by Barajas, R.F, Phillips, J.J, Vandenberg, S.R, McDermott, M.W, Berger, M.S, Dillon, W.P, Cha, S

“…Aim To investigate whether quantitative dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion magnetic resonance imaging (MRI) metrics are…”
Get full text

Outcomes and Prognostic Factors for Pineal Parenchymal Tumors: A 25 Year Single-Institution Experience by Raleigh, D, Lloyd, S, Solomon, D, Lazar, A, Tihan, T, Sneed, P.K, Clarke, J, Varenika, V, Garcia, M.A, Muller, S, Berger, M.S, Haas-Kogan, D.A

Get full text

Clinical Outcomes and Prognostic Factors for Central Neurocytoma by Imber, B.S, Braunstein, S.E, Wu, F.Y, Nabavizadeh, N, Boehling, N, Weinberg, V.K, Tihan, T, Chang, S, McDermott, M.W, Prados, M, Berger, M.S, Haas-Kogan, D.A

Get full text

Outcomes and Salvage Therapy for Recurrent Choroid Plexus Tumors: A 25-Year Single-Institution Experience by Garcia, M.A, Raleigh, D, Maghsoudi, K, Braunstein, S.E, Clarke, J, Sneed, P.K, Fogh, S.E, Larson, D.A, Nakamura, J.L, Barani, I.J, Mueller, S, Berger, M.S, Haas-Kogan, D.A

Get full text

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate by Sievers, E.L., Appelbaum, F.R., Spielberger, R.T., Forman, S.J., Flowers, D., Smith, F.O., Shannon-Dorcy, K., Berger, M.S., Bernstein, I.D.

“…Leukemic blast cells express the CD33 antigen in most patients with acute myeloid leukemia (AML), but this antigen is not expressed by hematopoietic stem…”
Get full text

Foreword by Berger, M.S.

Get full text

Pediatric Intracranial Ependymoma: The Roles of Surgery, Radiation, and Chemotherapy by Pejavar, S, Polley, M, Rosenberg-Wohl, S, Chennupati, S, Wara, W.M, Prados, M.D, Berger, M.S, Banerjee, A, Gupta, N, Haas-Kogan, D

Get full text

Tumor Regrowth Between Surgery and Initiation of Radiation Therapy in Patients With Newly Diagnosed GBM by Pirzkall, A, McGue, C, Saraswathy, S, Cha, S, Liu, R, Berger, M.S, Chang, S.M, Nelson, S.J

Get full text

Gamma Knife Radiosurgery for Brain Metastases From Primary Breast Cancer by Kased, N, Binder, D.K, Larson, D.A, Nakamura, J.L, Huang, K, Berger, M.S, McDermott, M.W, Sneed, P.K

Get full text

Signal Transduction Molecules in Gliomas of all Grades by Kaprealian, T, Ermoian, R.P, Lamborn, K.R, Jelluma, N, Arvold, N.D, Zeidman, R, Berger, M.S, Stokoe, D, Haas-Kogan, D.A

Get full text

Radiation Is an Important Component of Multimodality Therapy for Pediatric Supratentorial Neuroectodermal Tumors by Daganzo, S.M, Banerjee, A, Gupta, N, Lamborn, K.R, Prados, M.D, Berger, M.S, Wara, W.M, Haas-Kogan, D.A

Get full text

Long-Term Outcomes for Pediatric Low-Grade Hypothalamic/Chiasmatic Gliomas Treated on Phase II Chemotherapy Trial by Mishra, K.K, Squire, S, Lamborn, K.R, Banerjee, A, Berger, M.S, Prados, M.D, Haas-Kogan, D.A

“…Author Disclosure: K.K. Mishra, None; S. Squire, None; K.R. Lamborn, None; A. Banerjee, None; M.S. Berger, None; M.D. Prados, None; D.A. Haas-Kogan, None…”
Get full text

CRISPR-Based Epigenome Editing and Genome Wide Screening Define Mediators of Chemotherapy Response in Glioblastoma by Lin, K., Goudy, L., Pak, J., Foster, K., Payne, E., Ozawa, T., de Groot, J., Vasudevan, H., Raleigh, D., Gilbert, L.A., Berger, M.S., Liu, S.J.

“…Alkylating chemotherapies exhibit survival benefit for patients with glioblastoma (GBM), the most common malignant primary brain tumor. CRISPRoff is a…”
Get full text

Adjuvant Chemoradiotherapy within One Year of Resection for Molecularly Defined Astrocytoma by Liu, S.J., Chen, W.C., Zhang, Y., Young, J.S., Morshed, R.A., Nguyen, M.P., Villanueva-Meyer, J., Phillips, J., Oberheim, N.A., Aghi, M.K., Sneed, P.K., Braunstein, S.E., de Groot, J., Berger, M.S., Molinaro, A.M., Hervey-Jumper, S., Raleigh, D.

“…Treatments for diffuse low-grade gliomas (LGG) are controversial. Level I evidence supports the use of adjuvant radiotherapy (RT) and PCV chemotherapy for…”
Get full text

Identifying Gene-Treatment Interactions and Targetable Radiation Vulnerabilities in Glioblastoma through Coupling of In Vivo CRISPR Perturbation and Single Cell Transcriptomics by Liu, S.J., Pak, J., Zou, C., Payne, E., Foster, K., Vasudevan, H., Casey-Clyde, T., Seo, K., O'Loughlin, T., Wu, D., Lim, D., Ozawa, T., de Groot, J., Berger, M.S., Weiss, W., Gilbert, L.A., Raleigh, D.

“…Glioblastoma (GBM) is an incurable brain tumor comprised of dynamic malignant cell states and microenvironment components that underlie treatment resistance…”
Get full text

418 POSTER A phase I trial of GMX1777: an inhibitor of nicotinamide phosphoribosyl transferase (NAMPRT) by Pishvaian, M.J, Hwang, J.H, Malik, S, He, A.R, Deeken, J.F, Kelso, C.B, Dorsch-Vogel, K, Berger, M.S, Marshall, J.L

Get full text